2Kromer W. Similarities and difference in the properities of substituted benzimidazoles: a comparison between pantoprazole and related compounds[J]. Degestion, 1995, 56(5): 443.
3Beil W, Staar U, Sewing KF. Pantoprazole: a novel H^+/K^+ -ATP ase inhibitor with an improved pH stability[J]. Eur J Pharmacol, 1992, 218(23): 265.
5Chiverton SG,Howden CW,Burget DW,et al.Omeprezole (20 mg) daily given in the morning or evening:a comparison of effects on gastric acidity,and plasma gastrin and omeprezole concentration.Aliment Pharmacol Ther,1992,6:103-111.
6Williams MP,Sercombe J,Hamilton MI,et al.A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects.Aliment Pharmaco
7Ishizaki T,Horai Y.Review article:cytochrrome P450 and the metabolism of proton pump inhibitors-emphasis on rabeprazole.Aliment Pharmacol Ther,1999,13 Suppl 3:27-36.
8Katz PO,Anderson C,Khoury R,et al.Gastrtro-esophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.Aliment Pharmacol Ther,1998,93:1231-1234.
9Besancon M,Simon A,Sachs G,et al.Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.J Biol Chem,1997,272:22438-22446.
8Yang YX, Lewis JD,Epstein S,et al . Long-tern proton pump inhibi- tor therapy and risk of hip fracture[J]. JAMA. 2006,296(24) : 2947- 2953.
9Ho PM,Maddox MT,Wang L,et al. Risk of adverse outcomes asso- ciated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndromes [J]. JAMA, 2009, 301 (9): 937-944.
10Eichelbaum M, Ingelman WE Pharmacogenomics and individualized drug therapy[J]. Annu Rev Med,2006,57:119 137.
